Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,716
Total Claims
$797K
Drug Cost
962
Beneficiaries
$829
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-11%
Opioid rate vs peers
3.4% vs 3.8% avg
-29%
Cost per patient vs peers
$829 vs $1,174 avg
+35%
Brand preference vs peers
12.0% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.4%
Opioid Rate
293
Opioid Claims
$2,022
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,034 claims · $641K
Generic: 7,615 claims · $150K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 73 | $89K |
| Apixaban | 62 | $88K |
| Dapagliflozin Propanediol | 36 | $40K |
| Semaglutide | 24 | $38K |
| Rivaroxaban | 35 | $36K |
| Sacubitril/Valsartan | 39 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $19K |
| Evolocumab | 20 | $18K |
| Budesonide/Formoterol Fumarate | 15 | $14K |
| Tiotropium Bromide | 14 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $12K |
| Budesonide/Glycopyr/Formoterol | 14 | $9,240 |
| Insulin Nph Hum/Reg Insulin Hm | 21 | $8,516 |
| Fluticasone/Vilanterol | 12 | $8,187 |
| Levothyroxine Sodium | 427 | $8,181 |
Prescribing Profile
Patient Profile
74
Avg Age
63%
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data